V9V-17325-87164
3 vaccinations
3 coded responses
32 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 234 / VA
- Registered
- 2021-07-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-26
Dose 1 — Pfizer-BioNTech
-
2021-07-27
Registered in v-safe
-
2021-07-27
Survey response — days 1–6 daily, dose 1MedDRA: Pregnancy — Feeling: Good · Site: PainFree text: PregnancyMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-07-28
- 2021-07-29
- 2021-07-30
- 2021-07-31
- 2021-08-01
- 2021-08-02
- 2021-08-09
-
2021-08-16
Dose 2 — Pfizer-BioNTech
- 2021-08-16
- 2021-08-17
- 2021-08-18
- 2021-08-19
- 2021-08-20
- 2021-08-21
- 2021-08-22
- 2021-08-23
- 2021-08-30
- 2021-09-06
- 2021-09-13
- 2021-09-20
- 2021-09-27
- 2021-11-15
-
2022-02-10
Dose 3 — Pfizer-BioNTech
-
2022-02-10
Health check-in — day 0, dose 3Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2022-02-11
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
- 2022-02-12
-
2022-02-13
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-02-15
Survey response — days 1–6 daily, dose 3MedDRA: Mastitis — Feeling: Good · DiarrheaFree text: Dx mastitis, on cephalexinMedDRA releases: 2024-11 · check-in free text available
- 2022-02-19
-
2022-03-12
Survey response — day 28, dose 3MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: GoodFree text: Sore throat and stuffy noseMedDRA releases: 2024-11 · check-in free text available
- 2022-03-24
- 2022-05-14
- 2022-08-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-26 | Pfizer-BioNTech | No |
| 2 | 2021-08-16 | Pfizer-BioNTech | No |
| 3 | 2022-02-10 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Pregnancy
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Dx mastitis, on cephalexin
Release 11 — day 28, dose 3
Symptoms: Sore throat and stuffy nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SRO | Mastitis | · | · | ✓ |
| SRO | Pregnancy | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release